enVVeno Medical Corporation (NVNO) Free cash flow 2017–2025
enVVeno Medical Corporation (NVNO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$15.6MFY2025 · since FY2017: -$4.2M → -$15.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.6M | +7.7% |
| FY2024 | -$16.9M | +10.7% |
| FY2023 | -$18.9M | -20.1% |
| FY2022 | -$15.7M | -28.8% |
| FY2021 | -$12.2M | -55.5% |
| FY2020 | -$7.9M | -25.5% |
| FY2019 | -$6.3M | +1.7% |
| FY2018 | -$6.4M | -51.2% |
| FY2017 | -$4.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NVNO financial trends
NVNO RevenueNVNO Net incomeNVNO Net marginNVNO Gross profitNVNO Gross marginNVNO Operating incomeNVNO Operating marginNVNO Operating cash flowNVNO Capital expendituresNVNO Return on equityNVNO Stock buybacksNVNO Dividends paidNVNO Total assetsNVNO Total liabilitiesNVNO Shareholders’ equityNVNO overview →